Stay updated with breaking news from Unrolling. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company to present multiple recent Registry sub-studies driving cancer care innovation at ASCO 2022 Agendia, Inc., a commercial-stage company focused on improving outcomes for breast cancer patients
ST. LOUIS, May 03, 2022 (GLOBE NEWSWIRE) -- Curium announced today it has successfully enrolled and dosed patients in the ECLIPSE Trial. ECLIPSE is a Phase 3, multi-center, open-label, randomized clinical
Completion of enrollment is anticipated by calendar fourth quarter for the Phase 2b study of Edesa's potentially first-in-class, anti-inflammatory drugTORONTO, ON / ACCESSWIRE / April 28, 2022 / Edesa
He eve not detour and we've had the time to have the allies respond and the response m. is unrolling as it has opinion for weeks. >> who are you hearing on your end. >> so there's still a feeling that there's not an if but a when for an invague. the overwhelming propondrance of opinion and evidence continues to point to that being a large-scale invasion. what does that mean? this does not necessarily mean there's going to be russian troops storming across the border in all parts of ukraine, but there is a very real sense and concern that the large -- if you -- if you literally draw a line from...
Biden told president zelenskyy the u.s. will send another $500 million in aid to ukraine. congressman, earlier this month the president signed into law that massive spending package that included nearly $14 billion for military and humanitarian aid. the white house says the administration is preparing to offer more than a billion dollars in additional funding toward humanitarian assistance. is all of this going to be enough? >> i think it's hard to say. putin needs to stop his war. it's an unjust attack on ukraine. they have a right to self-defense and self-determination. i think people around...